-
Product Insights
La Gan Offshore Wind Project
La Gan Offshore Wind Project is an offshore wind project located in South China Sea, Vietnam. The project is owned by Asia Petroleum Energy Corp; Copenhagen Infrastructure Partners KS; Novasia Energy Co Ltd and is developed by La Gan Wind Power Development Corp. The project is expected to come online in 2026. Empower your strategies with our La Gan Offshore Wind Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon...
-
Company Insights
Innovation and Patenting activity of GAN Limited Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of GAN Limited Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be delivered...
-
Track & Monitor
Batteries in automotive: GaN battery chargers
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the automotive industry’s GaN battery chargers segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based...
-
Product Insights
Addu Intl Airport/ GIA – Gan International Airport Expansion – Southern Ari Atoll
Equip yourself with the essential tools needed to make informed and profitable decisions with our Addu Intl Airport/ GIA – Gan International Airport Expansion – Southern Ari Atoll report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Acquire a...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GZR-18 in Type 2 Diabetes
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GZR-18 in Type 2 Diabetes report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GZR-18 in Type 2 Diabetes Drug Details: GZR-18 is under development...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – BMS-986218 in Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BMS-986218 in Melanoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BMS-986218 in Melanoma Drug Details: BMS-986218 is under development for the treatment of...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Margetuximab in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Margetuximab in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Margetuximab in Non-Small Cell Lung Cancer Drug Details: Margetuximab (Margenza)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Margetuximab in Extrahepatic Bile Duct Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Margetuximab in Extrahepatic Bile Duct Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Margetuximab in Extrahepatic Bile Duct Cancer Drug Details: Margetuximab (Margenza)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GLR-2007 in Metastatic Brain Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GLR-2007 in Metastatic Brain Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GLR-2007 in Metastatic Brain Tumor Drug Details: GLR-2007 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GLR-2007 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GLR-2007 in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GLR-2007 in Non-Small Cell Lung Cancer Drug Details: GLR-2007 is...